[go: up one dir, main page]

DZ3055A1 - Polymorphes d'un chlorhydrate d'azo-bicyclo-2,2,2-oct-3-ylamine cristallins et compositions pharmaceutiques les contenant. - Google Patents

Polymorphes d'un chlorhydrate d'azo-bicyclo-2,2,2-oct-3-ylamine cristallins et compositions pharmaceutiques les contenant.

Info

Publication number
DZ3055A1
DZ3055A1 DZ000113A DZ000113A DZ3055A1 DZ 3055 A1 DZ3055 A1 DZ 3055A1 DZ 000113 A DZ000113 A DZ 000113A DZ 000113 A DZ000113 A DZ 000113A DZ 3055 A1 DZ3055 A1 DZ 3055A1
Authority
DZ
Algeria
Prior art keywords
polymorphs
bicyclo
oct
pharmaceutical compositions
compositions containing
Prior art date
Application number
DZ000113A
Other languages
English (en)
Inventor
Douglas John Meldrum Allen
Troy Anthony Appleton
Michael John Gumkoswki
David Joseph Muehlbauer
Timothy Norris
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Application granted granted Critical
Publication of DZ3055A1 publication Critical patent/DZ3055A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D455/00—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine
    • C07D455/02—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing not further condensed quinolizine ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DZ000113A 1999-06-22 2000-06-21 Polymorphes d'un chlorhydrate d'azo-bicyclo-2,2,2-oct-3-ylamine cristallins et compositions pharmaceutiques les contenant. DZ3055A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US14023399P 1999-06-22 1999-06-22

Publications (1)

Publication Number Publication Date
DZ3055A1 true DZ3055A1 (fr) 2004-03-27

Family

ID=22490317

Family Applications (1)

Application Number Title Priority Date Filing Date
DZ000113A DZ3055A1 (fr) 1999-06-22 2000-06-21 Polymorphes d'un chlorhydrate d'azo-bicyclo-2,2,2-oct-3-ylamine cristallins et compositions pharmaceutiques les contenant.

Country Status (35)

Country Link
US (1) US6262067B1 (fr)
EP (1) EP1187834A1 (fr)
JP (1) JP2003502425A (fr)
KR (1) KR20020030280A (fr)
CN (1) CN1390216A (fr)
AP (1) AP2001002367A0 (fr)
AR (1) AR024411A1 (fr)
AU (1) AU767336B2 (fr)
BG (1) BG106205A (fr)
BR (1) BR0011835A (fr)
CA (1) CA2375265A1 (fr)
CO (1) CO5190663A1 (fr)
CZ (1) CZ20014458A3 (fr)
DZ (1) DZ3055A1 (fr)
EA (1) EA004264B1 (fr)
EC (1) ECSP003538A (fr)
EE (1) EE200100698A (fr)
HR (1) HRP20010920A2 (fr)
HU (1) HUP0201694A3 (fr)
IL (1) IL146410A0 (fr)
IS (1) IS6161A (fr)
MA (1) MA26744A1 (fr)
MX (1) MXPA02000033A (fr)
NO (1) NO20016187D0 (fr)
NZ (1) NZ515348A (fr)
OA (1) OA11952A (fr)
PA (1) PA8496701A1 (fr)
PE (1) PE20010322A1 (fr)
PL (1) PL352899A1 (fr)
SK (1) SK18672001A3 (fr)
TN (1) TNSN00137A1 (fr)
TR (1) TR200103688T2 (fr)
UY (1) UY26211A1 (fr)
WO (1) WO2000078759A1 (fr)
ZA (1) ZA200110387B (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6387925B1 (en) * 1999-06-01 2002-05-14 Pfizer Inc. Polymorphs of a crystalline azo-bicyclo (2.2.2) oct-3-yl amine citrate and their pharmaceutical compositions
US6756379B2 (en) 2001-07-26 2004-06-29 Taro Pharmaceutical Industries Ltd. Non-sedating barbiturate compounds as neuroprotective agents
US7683071B2 (en) * 2000-07-26 2010-03-23 Taro Pharmaceuticals Industries Ltd. Composition and method for improved bioavailability and enhanced brain delivery of 5,5-diphenyl barbituric acid
US6939873B2 (en) 2000-07-26 2005-09-06 Taro Pharmaceuticals Industries Limited Non-sedating barbituric acid derivatives
JP2006503859A (ja) * 2002-10-04 2006-02-02 メルク シャープ エンド ドーム リミテッド 受容体拮抗薬としてのアザ二環式スピロエーテル誘導体
CN100502871C (zh) * 2002-12-11 2009-06-24 塔罗制药工业有限公司 巴比土酸衍生物在制备用于治疗运动障碍的药物中的应用
WO2006003651A2 (fr) * 2004-07-02 2006-01-12 Taro Pharmaceutical Industries, Ltd Procede de preparation d'acide 1-methoxymethyl-5,5-diphenylbarbiturique
US20080132529A1 (en) * 2006-11-14 2008-06-05 Avraham Yacobi Method of improving bioavailability for non-sedating barbiturates
UA102128C2 (en) * 2008-12-05 2013-06-10 Х. Луннбек А/С Nalmefene hydrochloride dihydrate
IL288547B2 (en) * 2019-06-03 2025-10-01 Biotheryx Inc Non-hygroscopic crystalline pyrazole compound salts, pharmaceutical preparations thereof and use thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX18467A (es) * 1988-11-23 1993-07-01 Pfizer Agentes terapeuticos de quinuclidinas
DE122006000066I2 (de) * 1991-05-31 2007-12-06 Pfizer Chinuclidinderivate
ES2096312T3 (es) * 1992-11-12 1997-03-01 Pfizer Derivado de quinuclidina como antagonista de la sustancia p.
US5393762A (en) * 1993-06-04 1995-02-28 Pfizer Inc. Pharmaceutical agents for treatment of emesis

Also Published As

Publication number Publication date
AU767336B2 (en) 2003-11-06
US6262067B1 (en) 2001-07-17
JP2003502425A (ja) 2003-01-21
EA200101179A1 (ru) 2002-06-27
PL352899A1 (en) 2003-09-22
AP2001002367A0 (en) 2001-12-31
IL146410A0 (en) 2002-07-25
EP1187834A1 (fr) 2002-03-20
NO20016187L (no) 2001-12-18
AR024411A1 (es) 2002-10-02
EA004264B1 (ru) 2004-02-26
TNSN00137A1 (fr) 2002-05-30
HRP20010920A2 (en) 2003-02-28
OA11952A (en) 2006-04-13
HUP0201694A3 (en) 2002-10-28
ZA200110387B (en) 2002-12-19
CN1390216A (zh) 2003-01-08
TR200103688T2 (tr) 2002-12-23
ECSP003538A (es) 2002-01-25
EE200100698A (et) 2003-02-17
AU4774500A (en) 2001-01-09
PA8496701A1 (es) 2002-07-30
UY26211A1 (es) 2001-01-31
MXPA02000033A (es) 2002-07-02
PE20010322A1 (es) 2001-03-14
NZ515348A (en) 2003-07-25
BG106205A (bg) 2002-07-31
WO2000078759A1 (fr) 2000-12-28
BR0011835A (pt) 2002-03-05
NO20016187D0 (no) 2001-12-18
CO5190663A1 (es) 2002-08-29
CZ20014458A3 (cs) 2002-03-13
SK18672001A3 (sk) 2002-08-06
CA2375265A1 (fr) 2000-12-28
KR20020030280A (ko) 2002-04-24
IS6161A (is) 2001-11-13
HUP0201694A2 (en) 2002-09-28
MA26744A1 (fr) 2004-12-20

Similar Documents

Publication Publication Date Title
FR2805818B1 (fr) Derives d'azetidine, leur preparation et les compositions pharmaceutiques les contenant
DZ2964A1 (fr) Diphénylurées substituées nouvelles, et compositions pharmaceutiques les contenant.
FR2789079B3 (fr) Derive d'acide pyrazolecarboxylique, sa preparation, les compositions pharmaceutiques en contenant
EE200100495A (et) Sahhariidijääkidega asendatud 1,4-bensotiasepiin-1,1-dioksiidi derivaadid, meetod nende valmistamiseks, ühendite kasutamine ning neid sisaldav ravim
DZ2594A1 (fr) Dérivés de 2-aminopyridine nouveaux et compositions pharmaceutiques les contenant.
MA27392A1 (fr) Nouveaux derives d'aminoindazoles a titre de medicaments et compositions pharmaceutiques les renfermant
DZ2461A1 (fr) Dérivés d'arylkylamines nouveaux et composition pharmaceutiques les contenant.
FR2807038B1 (fr) Nouveaux derives d'indolin-2-one, leur preparation et les compositions pharmaceutiques les contenant
EE9900441A (et) Farmatseutiline kompositsioon N-piperidino-3-pürasoolkarboksamiidi derivaadi, tema soolade ja nende solvaatide suu kaudu manustamiseks
DE69822209D1 (de) ESTRON-SULFatase HEMMENDE ESTRON-SULFAMATVERBINDUNGEN, PHARMAZEUTISCHE ZUSAMMENSETZUNGEN UND VERWENDUNGEN DAVON
MA26453A1 (fr) Derives de 6-phenylpyridyl-2 amine et compositions pharmaceutiques les contenant
EE04799B1 (et) Ühendid, mis on kasulikud põletikuvastaste vahenditena, nende ühendite valmistamise meetodid ja neid sisaldavad farmatseutilised kompositsioonid
HUP0302319A3 (en) Pharmaceutical composition for oral administration of active ingredient
FR2775596B1 (fr) Nouvelles compositions pharmaceutiques
EP1539730A4 (fr) Nouveaux composes, compositions pharmaceutiques les contenant et methodes d'utilisation desdits composes
HUP0201334A3 (en) Hydrochloride of fused-heterocycle compound and pharmaceutical compositions containing the same
FR2761066B1 (fr) Nouveaux derives du 2-(iminomethyl)amino-phenyle, leur preparation, leur application a titre de medicaments et les compositions pharmaceutiques les contenant
EE200200281A (et) Pikornaviirusevastased ühendid ja kompositsioonid, nende farmatseutilised kasutusalad ning ained nende sünteesiks
MA26547A1 (fr) Composes nouveaux, antagonistes des recepteurs de vitronectine, et compositions pharmaceutiques les contenant.
FR2740134B1 (fr) Derives d'amines cycliques d'aryl-piperazines, leur preparation et les compositions pharmaceutiques les contenant
DZ3055A1 (fr) Polymorphes d'un chlorhydrate d'azo-bicyclo-2,2,2-oct-3-ylamine cristallins et compositions pharmaceutiques les contenant.
FR2796380B3 (fr) Nouveaux derives d'aminothiazoles, leur preparation et les compositions pharmaceutiques les contenant
HUP0000960A3 (en) Spray-dried paroxetine hydrochloride, process for it's preparation,use of the compound and pharmaceutical compositions containing the same
CY2007011I1 (el) Πολυμορφες ενος κρυσταλλικου κιτρικου αλατος αζαδικυκλο (2,2,2) οκταν -3- αμινης και φαρμακευτικες συνθεσεις τους
PL350568A1 (en) N-(2-phenyl-4-aminobutyl)-1-naphtamides as antagonists of neurokinin 1 receptors